Agilent Technologies, Inc. $A Stock Holdings Increased by Wesleyan Assurance Society

Wesleyan Assurance Society boosted its position in Agilent Technologies, Inc. (NYSE:A) by 90.2% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 44,700 shares of the medical research company’s stock after buying an additional 21,200 shares during the quarter. Wesleyan Assurance Society’s holdings in Agilent Technologies were worth $5,272,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the company. Verdence Capital Advisors LLC increased its holdings in Agilent Technologies by 5.0% in the second quarter. Verdence Capital Advisors LLC now owns 1,818 shares of the medical research company’s stock valued at $215,000 after buying an additional 86 shares during the last quarter. Valeo Financial Advisors LLC grew its holdings in shares of Agilent Technologies by 3.0% during the first quarter. Valeo Financial Advisors LLC now owns 3,449 shares of the medical research company’s stock valued at $403,000 after purchasing an additional 102 shares during the last quarter. Cary Street Partners Financial LLC grew its holdings in shares of Agilent Technologies by 2.9% during the first quarter. Cary Street Partners Financial LLC now owns 3,688 shares of the medical research company’s stock valued at $431,000 after purchasing an additional 103 shares during the last quarter. Bartlett & CO. Wealth Management LLC grew its holdings in shares of Agilent Technologies by 5.1% during the first quarter. Bartlett & CO. Wealth Management LLC now owns 2,406 shares of the medical research company’s stock valued at $281,000 after purchasing an additional 116 shares during the last quarter. Finally, Stratos Wealth Partners LTD. grew its holdings in shares of Agilent Technologies by 0.3% during the first quarter. Stratos Wealth Partners LTD. now owns 41,334 shares of the medical research company’s stock valued at $4,835,000 after purchasing an additional 124 shares during the last quarter.

Analyst Upgrades and Downgrades

Several equities analysts have recently commented on A shares. Rothschild & Co Redburn started coverage on Agilent Technologies in a report on Wednesday, October 8th. They set a “buy” rating and a $165.00 target price for the company. Wells Fargo & Company upped their target price on Agilent Technologies from $140.00 to $150.00 and gave the company an “overweight” rating in a report on Monday, September 15th. Barclays upped their target price on Agilent Technologies from $125.00 to $150.00 and gave the company an “equal weight” rating in a report on Thursday, October 2nd. TD Cowen upped their target price on Agilent Technologies from $150.00 to $162.00 and gave the company a “buy” rating in a report on Tuesday, October 14th. Finally, JPMorgan Chase & Co. increased their price objective on Agilent Technologies from $155.00 to $165.00 and gave the stock an “overweight” rating in a report on Thursday, October 9th. One equities research analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating and six have issued a Hold rating to the stock. According to MarketBeat, Agilent Technologies has a consensus rating of “Moderate Buy” and an average price target of $149.62.

Agilent Technologies Stock Performance

Shares of A stock opened at $148.03 on Monday. Agilent Technologies, Inc. has a 12-month low of $96.43 and a 12-month high of $153.84. The firm has a market capitalization of $41.97 billion, a price-to-earnings ratio of 34.75, a price-to-earnings-growth ratio of 4.83 and a beta of 1.26. The business has a 50 day simple moving average of $130.39 and a 200 day simple moving average of $119.43. The company has a debt-to-equity ratio of 0.53, a current ratio of 2.25 and a quick ratio of 1.71.

Agilent Technologies (NYSE:A) last issued its quarterly earnings data on Wednesday, August 27th. The medical research company reported $1.37 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $1.37. The business had revenue of $1.74 billion during the quarter, compared to analyst estimates of $1.67 billion. Agilent Technologies had a return on equity of 25.51% and a net margin of 17.97%.The business’s revenue for the quarter was up 10.1% compared to the same quarter last year. During the same period in the prior year, the company posted $1.32 EPS. Agilent Technologies has set its FY 2025 guidance at 5.560-5.590 EPS. Q4 2025 guidance at 1.570-1.600 EPS. On average, equities research analysts anticipate that Agilent Technologies, Inc. will post 5.58 EPS for the current year.

Agilent Technologies Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Wednesday, October 22nd. Shareholders of record on Tuesday, September 30th were given a $0.248 dividend. This represents a $0.99 dividend on an annualized basis and a yield of 0.7%. The ex-dividend date was Tuesday, September 30th. Agilent Technologies’s dividend payout ratio is 23.24%.

Agilent Technologies Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.